EC Number | Cloned (Comment) | Organism |
---|---|---|
2.5.1.26 | AGPS expression anaysis by quantitative RT-PCR analysis | Mus musculus |
2.5.1.26 | AGPS expression anaysis by quantitative RT-PCR analysis | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.5.1.26 | additional information | generation of homo- and heterozygous APP knock-out mice, APP-/-, APP+/-, and mice expressing a truncated amyloid precursor protein, APP, the construct lacks the last 15 amino acids, APPDELTA/DELTA, that includes the presumably critical YENPTY motif, where adaptor proteins like Fe65 and X11 are proposed to bind through their phosphotyrosine-binding domains and which are responsible for nuclear targeting of APP intracellular domain | Mus musculus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.5.1.26 | peroxisome | - |
Mus musculus | 5777 | - |
2.5.1.26 | peroxisome | - |
Homo sapiens | 5777 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.5.1.26 | 1-acyl-glycerone 3-phosphate + a long-chain alcohol | Mus musculus | - |
an alkyl-glycerone 3-phosphate + a long-chain acid anion | - |
? | |
2.5.1.26 | 1-acyl-glycerone 3-phosphate + a long-chain alcohol | Homo sapiens | - |
an alkyl-glycerone 3-phosphate + a long-chain acid anion | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.5.1.26 | Homo sapiens | - |
- |
- |
2.5.1.26 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.5.1.26 | brain | - |
Mus musculus | - |
2.5.1.26 | brain | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.5.1.26 | 1-acyl-glycerone 3-phosphate + a long-chain alcohol | - |
Mus musculus | an alkyl-glycerone 3-phosphate + a long-chain acid anion | - |
? | |
2.5.1.26 | 1-acyl-glycerone 3-phosphate + a long-chain alcohol | - |
Homo sapiens | an alkyl-glycerone 3-phosphate + a long-chain acid anion | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.5.1.26 | AGPS | - |
Mus musculus |
2.5.1.26 | AGPS | - |
Homo sapiens |
2.5.1.26 | alkyl-dihydroxyacetonephosphate-synthase | - |
Mus musculus |
2.5.1.26 | alkyl-dihydroxyacetonephosphate-synthase | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.5.1.26 | Homo sapiens | the amyloid precursor protein intracellular domain increases the expression of the alkyl-dihydroxyacetonephosphate-synthase in vivo and in vitro | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.5.1.26 | malfunction | AGPS protein level and phosphatidylethanolamine plasmalogen level are decreased in amyloid-beta protein precursor-deficient cells and brains, overview | Mus musculus |
2.5.1.26 | malfunction | AGPS protein level and phosphatidylethanolamine plasmalogen level are decreased in amyloid-beta protein precursor-deficient cells and brains, overview | Homo sapiens |
2.5.1.26 | metabolism | alkyl-dihydroxyacetonephosphate-synthase, AGPS, is a rate limiting enzyme in plasmalogen synthesis, catalyzing the initial committed step in plasmalogen synthesis, phosphatidylethanolamine plasmalogen de novo synthesis, overview. Plasmalogens are major brain lipids | Mus musculus |
2.5.1.26 | metabolism | alkyl-dihydroxyacetonephosphate-synthase, AGPS, is a rate limiting enzyme in plasmalogen synthesis, catalyzing the initial committed step in plasmalogen synthesis, phosphatidylethanolamine plasmalogen de novo synthesis, overview. Plasmalogens are major brain lipids | Homo sapiens |
2.5.1.26 | physiological function | plasmalogens are decreased as a consequence of Alzheimer's disease and regulated by amyloid-beta precursor protein processing under physiological conditions. Under the pathological situation of Alzheimer's disease, increased amyloid-beta levels lead to increased reactive oxidative species production, reduced AGPS protein and plasmalogen level, overview. Alterations in amyloid precursor protein-dependent changes of AGPS expression result in reduced protein and plasmalogen levels | Homo sapiens |